Olamkina: Amlodipine Besylate Tablets Obtained Drug Registration Certificate.

On the evening of July 3, Anglikang announced that the company has received the drug registration certificate for amlodipine besylate tablets issued by the National Medical Products Administration. This drug is used for symptomatic treatment of chronic stable angina and for the treatment of hypertension.